Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review

Abstract Background Human Papilloma Virus (HPV) is the most common sexually transmitted infection worldwide. Globally, both men and women have a 50% risk of being infected at least once in their life. HPV prevalence is among the highest in sub-Saharan Africa (SSA), at an average of 24%. HPV causes d...

Full description

Bibliographic Details
Main Authors: Jean-Marc Kutz, Pia Rausche, Tarik Gheit, Dewi Ismajani Puradiredja, Daniela Fusco
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-023-15842-1
_version_ 1827939663524921344
author Jean-Marc Kutz
Pia Rausche
Tarik Gheit
Dewi Ismajani Puradiredja
Daniela Fusco
author_facet Jean-Marc Kutz
Pia Rausche
Tarik Gheit
Dewi Ismajani Puradiredja
Daniela Fusco
author_sort Jean-Marc Kutz
collection DOAJ
description Abstract Background Human Papilloma Virus (HPV) is the most common sexually transmitted infection worldwide. Globally, both men and women have a 50% risk of being infected at least once in their life. HPV prevalence is among the highest in sub-Saharan Africa (SSA), at an average of 24%. HPV causes different types of cancers, including cervical cancer (CC), which is the leading cause of cancer deaths among women in SSA. HPV-vaccination has been proven to be effective in reducing HPV induced cancers. SSA countries are delayed in reaching the WHO’s target of fully vaccinating 90% of girls within the age of 15 by 2030. Our systematic review aims to identify barriers and facilitators of HPV-vaccination in SSA to inform national implementation strategies in the region. Methods This is a mixed method systematic review based on the PRISMA statement and The Joanna Briggs Institute Reviewers’ Manual. Search strategies were adapted to each selected database: PubMed/MEDLINE, Livivo, Google Scholar, Science Direct, and African Journals Online for papers published in English, Italian, German, French and Spanish between 1 December 2011 and 31 December 2021. Zotero and Rayyan were the software used for data management. The appraisal was conducted by three independent reviewers. Results A total of 20 articles were selected for appraisal from an initial 536 articles. Barriers included: limited health system capacities, socio-economic status, stigma, fear and costs of vaccines, negative experience with vaccinations, COVID-19 pandemic, lack of correct information, health education (HE) and consent. Additionally, we found that boys are scarcely considered for HPV-vaccination by parents and stakeholders. Facilitators included: information and knowledge, policy implementation, positive experience with vaccinations, HE, stakeholders’ engagement, women’s empowerment, community engagement, seasonality, and target-oriented vaccination campaigns. Conclusions This review synthesizes barriers and facilitators of HPV-vaccinations in SSA. Addressing these can contribute to the implementation of more effective HPV immunization programs targeted at eliminating CC in line with the WHO 90/70/90 strategy. Registration and funding Protocol ID: CRD42022338609 registered in the International Prospective Register of Systematic Reviews (PROSPERO). Partial funds: German Centre for Infection research (DZIF) project NAMASTE: 8,008,803,819.
first_indexed 2024-03-13T08:58:38Z
format Article
id doaj.art-9a2510f01e1e4deeaa413675ec8f2476
institution Directory Open Access Journal
issn 1471-2458
language English
last_indexed 2024-03-13T08:58:38Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj.art-9a2510f01e1e4deeaa413675ec8f24762023-05-28T11:30:15ZengBMCBMC Public Health1471-24582023-05-0123111310.1186/s12889-023-15842-1Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic reviewJean-Marc Kutz0Pia Rausche1Tarik Gheit2Dewi Ismajani Puradiredja3Daniela Fusco4Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM)Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM)International Agency for Research on Cancer (IARC)Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM)Department of Infectious Diseases Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM)Abstract Background Human Papilloma Virus (HPV) is the most common sexually transmitted infection worldwide. Globally, both men and women have a 50% risk of being infected at least once in their life. HPV prevalence is among the highest in sub-Saharan Africa (SSA), at an average of 24%. HPV causes different types of cancers, including cervical cancer (CC), which is the leading cause of cancer deaths among women in SSA. HPV-vaccination has been proven to be effective in reducing HPV induced cancers. SSA countries are delayed in reaching the WHO’s target of fully vaccinating 90% of girls within the age of 15 by 2030. Our systematic review aims to identify barriers and facilitators of HPV-vaccination in SSA to inform national implementation strategies in the region. Methods This is a mixed method systematic review based on the PRISMA statement and The Joanna Briggs Institute Reviewers’ Manual. Search strategies were adapted to each selected database: PubMed/MEDLINE, Livivo, Google Scholar, Science Direct, and African Journals Online for papers published in English, Italian, German, French and Spanish between 1 December 2011 and 31 December 2021. Zotero and Rayyan were the software used for data management. The appraisal was conducted by three independent reviewers. Results A total of 20 articles were selected for appraisal from an initial 536 articles. Barriers included: limited health system capacities, socio-economic status, stigma, fear and costs of vaccines, negative experience with vaccinations, COVID-19 pandemic, lack of correct information, health education (HE) and consent. Additionally, we found that boys are scarcely considered for HPV-vaccination by parents and stakeholders. Facilitators included: information and knowledge, policy implementation, positive experience with vaccinations, HE, stakeholders’ engagement, women’s empowerment, community engagement, seasonality, and target-oriented vaccination campaigns. Conclusions This review synthesizes barriers and facilitators of HPV-vaccinations in SSA. Addressing these can contribute to the implementation of more effective HPV immunization programs targeted at eliminating CC in line with the WHO 90/70/90 strategy. Registration and funding Protocol ID: CRD42022338609 registered in the International Prospective Register of Systematic Reviews (PROSPERO). Partial funds: German Centre for Infection research (DZIF) project NAMASTE: 8,008,803,819.https://doi.org/10.1186/s12889-023-15842-1Human papillomavirus viruses [Mesh]Papillomavirus Vaccines [Mesh]Sub-Saharan Africa [Mesh]Uterine cervical neoplasms [Mesh]
spellingShingle Jean-Marc Kutz
Pia Rausche
Tarik Gheit
Dewi Ismajani Puradiredja
Daniela Fusco
Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
BMC Public Health
Human papillomavirus viruses [Mesh]
Papillomavirus Vaccines [Mesh]
Sub-Saharan Africa [Mesh]
Uterine cervical neoplasms [Mesh]
title Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
title_full Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
title_fullStr Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
title_full_unstemmed Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
title_short Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
title_sort barriers and facilitators of hpv vaccination in sub saharan africa a systematic review
topic Human papillomavirus viruses [Mesh]
Papillomavirus Vaccines [Mesh]
Sub-Saharan Africa [Mesh]
Uterine cervical neoplasms [Mesh]
url https://doi.org/10.1186/s12889-023-15842-1
work_keys_str_mv AT jeanmarckutz barriersandfacilitatorsofhpvvaccinationinsubsaharanafricaasystematicreview
AT piarausche barriersandfacilitatorsofhpvvaccinationinsubsaharanafricaasystematicreview
AT tarikgheit barriersandfacilitatorsofhpvvaccinationinsubsaharanafricaasystematicreview
AT dewiismajanipuradiredja barriersandfacilitatorsofhpvvaccinationinsubsaharanafricaasystematicreview
AT danielafusco barriersandfacilitatorsofhpvvaccinationinsubsaharanafricaasystematicreview